• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES PR FOGARTY; CATHETER, EMBOLECTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES PR FOGARTY; CATHETER, EMBOLECTOMY Back to Search Results
Model Number 120602F
Medical Device Problem Code Detachment of Device or Device Component (2907)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The device evaluation is anticipated.A supplemental report will be forthcoming when the investigation is completed.A device history record review was unable to be completed as the lot number is unknown.Complaint histories for all reported events are reviewed against trending control limits on a monthly basis and any excursions above the control limits are assessed and documented as a part of the monthly review.
 
Event or Problem Description
It was reported that during use of the embolectomy catheter, the tip became separated.The issue occurred when attempting to pass the embolectomy catheter distally in the ulnar, and the user was met with significant resistance pulling back.The patient required a cut down of the ulnar artery to retrieve the tip of the catheter.There was no patient injury.
 
Additional Manufacturer Narrative
One model 120602f catheter was returned for evaluation.The customer report of separated tip of the embolectomy catheter was confirmed.As received, the spring tip was stretched.Catheter body, under proximal balloon windings, was broke.Surfaces at the break appeared to match up.Proximal balloon windings was partially unraveled.Distal windings and balloon were intact.No other visible damage was observed from catheter body.The lot number was not provided thus a device history record was not reviewed.An engineering evaluation was initiated to assess for any manufacturing-related processes which could be correlated to the complaint.Based on the available information there is no evidence that supports or confirms the failure mode is associated to a manufacturing/design defect.As part of the manufacturing process, 100% of the units undergo an inflation test and visual inspection.The instructions for use also contain the following warnings and precautions: balloon rupture and catheter separation as a result of excessive pull force applied to remove adherent material are the most frequent causes of reported failures.To minimize the risk of vessel damage, balloon rupture, or tip detachment, do not exceed the maximum recommended inflation and pull force for each size catheter.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FOGARTY
Common Device Name
CATHETER, EMBOLECTOMY
Manufacturer (Section D)
EDWARDS LIFESCIENCES PR
state rd indus pk 402 km 1.4
anasco
Manufacturer (Section G)
BD APM
17200 laguna canyon rd
irvine CA 92603
Manufacturer Contact
erika bonilla
1 edwards way
irvine, CA 92614
MDR Report Key23335991
Report Number2015691-2025-08642
Device Sequence Number9470949
Product Code DXE
UDI-Device Identifier00690103043273
UDI-Public00690103043273
Combination Product (Y/N)N
Initial Reporter StateWV
Initial Reporter CountryUS
PMA/510(K) Number
NI
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,User Facility
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 12/22/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number120602F
Was Device Available for Evaluation? Device Returned to Manufacturer
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/25/2025
Supplement Date Received by Manufacturer12/22/2025
Initial Report FDA Received Date10/20/2025
Supplement Report FDA Received Date12/22/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age87 YR
Patient SexFemale
Patient Weight56 KG
-
-